IL285822A - Methods for treating organic acidosis - Google Patents
Methods for treating organic acidosisInfo
- Publication number
- IL285822A IL285822A IL285822A IL28582221A IL285822A IL 285822 A IL285822 A IL 285822A IL 285822 A IL285822 A IL 285822A IL 28582221 A IL28582221 A IL 28582221A IL 285822 A IL285822 A IL 285822A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- treating organic
- organic acidemias
- acidemias
- treating
- Prior art date
Links
- 201000008152 organic acidemia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962818372P | 2019-03-14 | 2019-03-14 | |
| PCT/US2020/022760 WO2020186216A1 (en) | 2019-03-14 | 2020-03-13 | Methods of treating organic acidemias |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL285822A true IL285822A (en) | 2021-10-31 |
Family
ID=72426817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL285822A IL285822A (en) | 2019-03-14 | 2021-08-24 | Methods for treating organic acidosis |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220142955A1 (https=) |
| EP (1) | EP3937922A4 (https=) |
| JP (1) | JP2022525339A (https=) |
| KR (1) | KR20210139274A (https=) |
| CN (1) | CN113557014A (https=) |
| AU (1) | AU2020236023A1 (https=) |
| BR (1) | BR112021018036A2 (https=) |
| CA (1) | CA3133260A1 (https=) |
| EA (1) | EA202192497A1 (https=) |
| IL (1) | IL285822A (https=) |
| WO (1) | WO2020186216A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022216848A1 (en) * | 2021-04-06 | 2022-10-13 | Hemoshear Therapeutics, Inc. | Methods of treating methylmalonic acidemia and propionic acidemia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1249706B (it) * | 1991-09-18 | 1995-03-09 | Sigma Tau Ind Farmaceuti | Uso di l-carnitina nella gravidanza a rischio. |
| AU3889197A (en) * | 1996-07-26 | 1998-02-20 | Douglas V Faller | Compositions comprising an inducing agent and an anti-viral agent for the treat ment of blood, viral and cellular disorders |
| US20050027006A1 (en) * | 2003-07-28 | 2005-02-03 | Reuben Matalon | Methods and materials for treating conditions associated with metabolic disorders |
| WO2011072086A1 (en) * | 2009-12-08 | 2011-06-16 | Hemaquest Pharmaceuticals, Inc. | Methods and low dose regimens for treating red blood cell disorders |
| US20120289476A1 (en) * | 2009-12-11 | 2012-11-15 | Jay Allan Barth | Methods for treating methylmalonic acidemia |
| US9018176B2 (en) * | 2010-12-02 | 2015-04-28 | Susan Perrine | Inducers of hematopoiesis and fetal globin production for treatment of cytopenias and hemoglobin disorders |
| ES2795798T3 (es) * | 2011-07-06 | 2020-11-24 | Ptc Therapeutics Inc | Tratamiento de aciduria metilmalónica, aciduria isovalérica, y otras acidurias orgánicas con tocotrienol quinonas |
| EP2877444B1 (en) * | 2012-07-27 | 2020-09-02 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
| US20180064154A9 (en) * | 2015-09-01 | 2018-03-08 | D. Holmes Morton | Management of propionate metabolism disorders |
| JO3543B1 (ar) * | 2015-09-28 | 2020-07-05 | Applied Pharma Res | تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم |
| WO2017139697A1 (en) * | 2016-02-10 | 2017-08-17 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
| WO2017184583A1 (en) * | 2016-04-19 | 2017-10-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Anaplerotic agents for treatment of disorders of propionate and long chain fat metabolism |
-
2020
- 2020-03-13 EP EP20770425.5A patent/EP3937922A4/en not_active Withdrawn
- 2020-03-13 WO PCT/US2020/022760 patent/WO2020186216A1/en not_active Ceased
- 2020-03-13 AU AU2020236023A patent/AU2020236023A1/en not_active Abandoned
- 2020-03-13 KR KR1020217029827A patent/KR20210139274A/ko not_active Ceased
- 2020-03-13 JP JP2021555384A patent/JP2022525339A/ja active Pending
- 2020-03-13 BR BR112021018036A patent/BR112021018036A2/pt not_active Application Discontinuation
- 2020-03-13 EA EA202192497A patent/EA202192497A1/ru unknown
- 2020-03-13 CA CA3133260A patent/CA3133260A1/en active Pending
- 2020-03-13 US US17/438,560 patent/US20220142955A1/en not_active Abandoned
- 2020-03-13 CN CN202080020521.7A patent/CN113557014A/zh active Pending
-
2021
- 2021-08-24 IL IL285822A patent/IL285822A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3937922A4 (en) | 2022-11-30 |
| CA3133260A1 (en) | 2020-09-17 |
| EP3937922A1 (en) | 2022-01-19 |
| JP2022525339A (ja) | 2022-05-12 |
| US20220142955A1 (en) | 2022-05-12 |
| WO2020186216A1 (en) | 2020-09-17 |
| CN113557014A (zh) | 2021-10-26 |
| BR112021018036A2 (pt) | 2021-11-23 |
| KR20210139274A (ko) | 2021-11-22 |
| EA202192497A1 (ru) | 2021-11-18 |
| AU2020236023A1 (en) | 2021-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202108029XA (en) | Methods of treating multiple myeloma | |
| IL283337A (en) | Methods for treating whsc1-overexpressing cancers by inhibiting setd2 | |
| SG11202112232YA (en) | Methods of treating neuropathy | |
| IL284797A (en) | Addiction treatment methods | |
| ZA202203776B (en) | Methods of treating epilepsy using the same | |
| IL277981A (en) | Cancer treatment methods | |
| IL287210A (en) | Preparations for the treatment of tumors | |
| SG11202010793UA (en) | Methods of treating cancer | |
| IL281600B2 (en) | Cancer treatment methods | |
| IL284791A (en) | Disease treatment methods with MAGL inhibitors | |
| IL290983A (en) | Treatment methods | |
| IL288353A (en) | Methods for treating cholangiocarcinoma | |
| IL289811A (en) | A method for treating cancer | |
| IL287250A (en) | treatment method | |
| SG11202107017TA (en) | Methods of treating cancer | |
| EP3856867B8 (en) | Treatment of iron sulphide deposits | |
| ZA201906319B (en) | Methods of treating depression | |
| HUE049463T2 (hu) | Eljárás kavicsok kezelésére | |
| IL285822A (en) | Methods for treating organic acidosis | |
| GB201918853D0 (en) | Methods of treatment | |
| SG11202102240YA (en) | Methods of treating psoriasis | |
| SG11202105877YA (en) | Method of treatment | |
| IL290853A (en) | Treatment methods using omelizumab | |
| HK40066171A (en) | Methods of treating organic acidemias | |
| GB201911056D0 (en) | Treatment of ADD/ADHD |